NASDAQ:DNAC - Nasdaq - KYG8253W1096 - Common Stock
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
Palihapitiya's SPAC with ProKidney is expected to close during Q3 of this year. Here's what you need to know about the biotech company.
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
/PRNewswire/ -- Halper Sadeh LLP, an investor rights law firm, is investigating the following companies for potential violations of the federal securities laws...
SPACs may make a comeback in 2022. But some of them won't ever recover. These 7 SPACs have a challenging future ahead of themselves.
/PRNewswire/ -- Brodsky & Smith reminds investors of the following investigations. If you own shares and wish to discuss the investigation, contact Jason...
Mentions: ZGNX
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Exterran Corporation (NYSE: EXTN)...
/PRNewswire/ -- Halper Sadeh LLP, a global investor rights law firm, announces it is investigating the following companies: Viveon Health Acquisition Corp....
ProKidney LP agreed to become a publicly-traded company via a business combination with Chamath Palihapitiya-backed special purpose acquisition company Social Capital...
Mentions: RPRX
SoFi Technologies (SOFI) stock is on the move Tuesday as investors discuss a bank charter for the company and what it could do to the stock.
Roblox (RBLX) stock is on the rise Tuesday despite a lack of news from the gaming and game development platform but lots of chatter.
Investors are excited to hear that dealmaker Chamath Palihapitiya is proceeding with a new SPAC deal involving ProKidney.
The 2022 year has started quietly for SPACs, with no deals announced in the first five trading days of the year. Although two new SPAC rumors have popped up since the market...
In Chamath Palihapitiya's latest SPAC empire-building move, his four new new biotech SPACs in the genomics and biotech space are making waves.